Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06668766 · ClinicalTrials.gov registry record · NA

Single Lumen Midline Catheter vs Long Peripheral Intravenous Cather for Difficult Intravenous Access in the ED

A NA study of Emergency Department Patient and Midline Catheter, sponsored by Albany Medical College.

Recruiting
Registry status
NA
Development phase
270
Enrollment target
1
Study location

NCT06668766: Recruiting NA study of Emergency Department Patient and Midline Catheter, sponsored by Albany Medical College.

NCT06668766 is a NA study of Emergency Department Patient and Midline Catheter that is actively recruiting participants, run by Albany Medical College. The registered enrollment target is 270 participants, roughly in line with the 293-participant average among 5 other Emergency Department Patient trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06668766, a NA study of Emergency Department Patient and Midline Catheter, is actively recruiting participants, sponsored by Albany Medical College.

RECRUITING
Registry status
NA
Development phase
270 participants
Enrollment target
1
Study location

Study Summary

Many patients in the emergency department have veins that are difficult to get an intrevenous (IV) catheter into (called "difficult IV access"). These patients may require other methods to obtain access to a vein for administration of the necessary medications. The 2-inch long IV is most commonly used in emergency departments for people with difficulty IV access. Typically, a healthcare worker will use an ultrasound to help to see the veins underneath the skin while inserting the IV into the vein. That is, the ultrasound helps the healthcare worker visualize veins that are deeper in the arm and may not be felt through the skin. Another device that can be used is a 4-inch midline catheter. This device is less commonly used as many emergency departments do not have participants available, but it serves the same purpose as the 2-inch long IVs (that is, to give medicine into the vein and sometimes to take blood). A 4-inch midline catheter is similar to a 2-inch long IV, but has a few differences. First, the 4-inch midline catheter is even longer than the 2-inch long IV. The 4-inch midline catheter is 10-cm (about 4-inches or the size of 4 quarters side-by-side), while the 2-inch long IV is 4.78-cm (nearly 2-inches or two quarters side-by-side). Second, the 4-inch midline catheter is inserted into using a guidewire to help move the catheter in the vein (similar in concept to a train moving along a track), while the 2-inch long IV does not have this guidewire. The guidewire does not hurt and most do not know it is being used. It is just an additional step to help guide the catheter in the vein. The investigators are conducting this research study to determine which catheter is better for patients with difficult IV access: the 4-inch midline catheter or the 2-inch long IV.

Primary Outcome

Catheter dwell time until completion of care will be measured. Completion of care will be considered to be the time of insertion of the study VAD to either a) discharge from the hospital or b) a documented completion of need for IV therapy warranting removal of the study VAD. Overall catheter survival will be determined by how long the catheter is in place and functional. We will report data based on a Kaplan Meier curve to display catheter survival.

Interventions

  • DEVICE 10-cm Single Lumen Mildine
  • DEVICE 4.78 cm Long Peripheral Intravenous Catheter

Study Locations (1)

New York

  • Albany Medical Center Hospital - Albany

Trial Details

FieldValue
Enrollment Target 270 participants
Start Date 2025-01-01
Est. Completion 2027-10-21
Phase NA
Albany Medical College

52 total trials

What NCT06668766 shows while recruiting

NCT06668766 is an interventional study that assigns participants to a tested intervention. The registered 270 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 293-participant average among 5 other Emergency Department Patient trials with a reported enrollment target.

The record links to 4 conditions, with Emergency Department Patient appearing as the primary indexed condition, and to 2 interventions - of which 10-cm Single Lumen Mildine is the first listed.

NCT06668766 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT06668766 about?

NCT06668766 is a clinical study titled "Single Lumen Midline Catheter vs Long Peripheral Intravenous Cather for Difficult Intravenous Access in the ED". Many patients in the emergency department have veins that are difficult to get an intrevenous (IV) catheter into (called "difficult IV access"). These patients may require other methods to obtain access to a vein for administration of the necessary medications. The 2-inch long IV is most commonly us...

What is the current status of trial NCT06668766?

This trial is currently recruiting. It is a NA study. The enrollment target is 270 participants. The study started on 2025-01-01. Estimated completion is 2027-10-21.

What conditions does trial NCT06668766 study?

This clinical trial studies the following conditions: Emergency Department Patient, Midline Catheter, Difficult Intravenous Access, Peripheral Intravenous Catheter.

What interventions are being tested in trial NCT06668766?

The interventions under investigation include: 10-cm Single Lumen Mildine (DEVICE), 4.78 cm Long Peripheral Intravenous Catheter (DEVICE).

Who is sponsoring clinical trial NCT06668766?

This trial is sponsored by Albany Medical College, which has 52 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06668766 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Emergency Department Patient

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00801489 · 270 participants · Phase 2

    Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

  • NCT04372485 · 270 participants · NA

    Using Mobile Health (mHealth) to Improve STI Treatment Adherence Among Adolescents

  • NCT04528446 · 270 participants

    The Impact of Glomerular Disorders on Bone Quality and Strength

  • NCT05215327 · 270 participants · Phase 2

    High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06668766, the US trial registry maintained by the National Library of Medicine. NCT06668766 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.